What's on?

Bone marrow cancer remission thanks to measles virus

16 May 2014 | By Inserm (Newsroom) | International

Photo ©Inserm/Fournier, Jean-Guy

Article published in the “Mayo Clinic Proceedings” journal describing complete remission of a 49-year old patient (after more than 6 months) suffering from bone marrow cancer following an injection of a strong dosage of the modified measles virus. The Mayo Clinic researchers have been using this to vaccinate 10 million people.

Reach the scientific article

Read the press release

Inserm researchers are able to comment this study at the Inserm unit 892 “Centre régional de recherche en cancérologie -nantes-angers”:

Marc Grégoire, Inserm research director
Head of team “Innovative therapeutic strategies inducing immune responses: application to the treatments of mesothelioma”
Cell phone available by request at the Inserm press office. rf.mresni@esserp

Jean-François Fonteneau
Inserm researcher
02 28 08 02 39

Mathieu Mateo
Post-PhD student at the Mayo Clinic

Researcher Contact

Marc Grégoire, directeur de recherche à l’Inserm
Responsable de l’équipe “stratégies thérapeutiques innovantes induisant des réponses immunitaires : application aux traitements du mésotheliome”
Téléphone portable sur demande au service de presse – voir contact presse

Jean-François Fonteneau
Chargé de recherche Inserm
02 28 08 02 39 rf.mresni@uaenetnof.siocnarf-naej

Press Contact

Juliette Hardy 
01 44 23 60 98